-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Mereo BioPharma Group plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2023 to Q2 2024.
- Mereo BioPharma Group plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 712M shares, a 13.3% increase year-over-year.
- Mereo BioPharma Group plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 659M shares, a 9.33% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)